<DOC>
	<DOC>NCT01726010</DOC>
	<brief_summary>The goal of this prospective study is to evaluate the feasibility of the 22-G Core Biopsy Needle with reverse bevel (Procore TM) in biopsy sampling of subepithelial tumors of the upper gastrointestinal tract.</brief_summary>
	<brief_title>22-G-Procore Needle for the Diagnosis of SETs of the Upper GI Tract</brief_title>
	<detailed_description />
	<criteria>1. Patient age 18 years and older 2. All patients with subepithelial tumors of the upper GI tract (maximum size: 3 cm) 1. Unable to obtain informed consent 2. ASA class 4 or 5 3. known pregnancy 4. contraindication endoscopy 5. contraindication for taking biopsies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>